SoliMix Study Results Summary
Discover clinical outcomes with iGlarLixi versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial leading to advancing therapy in sub-optimally controlled basal insulin-treated Type-2 diabetes.
.jpg3/jcr:content/image%20(52).jpg)
SoliMix Results Summary Video - amended_LinkedIn Group_Ibrahim
.jpg0/jcr:content/image%20(54).jpg)
MAT-BH-2300623/v1/November2023